Senokot-S (standardizedsenna concentrate and docusate sodium)

Drug Facts

Active ingredients (in each tablet)

Docusate sodium 50mg

Sennosides 8.6mg

Purpose

Stool softener

Laxative

Uses

relieves occasional constipation (irregularity)
generally produces a bowel movement in 6-12 hours

Warnings

Do not use

if you are now taking mineral oil, unless directed by adoctor
laxative products for longer than 1 week unless directedby a doctor

Ask a doctor before use if you have

stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues overa period of 2 weeks

Stop using and ask a doctor if youhave rectal bleeding or fail to have a bowel movement after use ofa laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reachof children.

In case ofoverdose, get medical help or contact a Poison Control Center rightaway.

Directions

take preferably at bedtime or as directed by a doctor

age	startingdosage	maximumdosage
adults and children 12 years of age and over	2 tablets oncea day	4 tablets twicea day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

each tablet contains: calcium 7 mg, sodium 4 mg VERYLOW SODIUM
store at 25°C (77°F); excursions permitted between 15°-30°C(59°-86°F)

Inactive ingredients

Inactive ingredients croscarmellose sodium, dicalcium phosphate, FD&C Yellow#5 Lake*, FD&C Yellow #6 Lake, hypromellose, magnesium stearate,maltodextrin, microcrystalline cellulose, mineral oil, polyethyleneglycol, sodium benzoate, sodium lauryl sulfate, starch, stearic acid,talc, titanium dioxide, triacetin

Avrio Health L.P.

A1023

Senokot-S 60 Tablets Label
NDC: 67618-310-60

Senokot-S 60 Tablets Leaflet
NDC: 67618-310-60

Senokot-S 60 Tablets Carton
NDC: 67618-310-60

Senokot-S 10 Tablets Carton
NDC: 67618-310-01

SENOKOT-S
standardized senna concentrate and docusate sodium tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:67618-310
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG)	DOCUSATE SODIUM	50 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: L11K75P92J)
FD&C YELLOW NO. 5 (UNII: I753WB2F1M)
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
MINERAL OIL (UNII: T5L8T28FGP)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
SODIUM BENZOATE (UNII: OJ245FE5EU)
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
STARCH, CORN (UNII: O8232NY3SJ)
STEARIC ACID (UNII: 4ELV7Z65AP)
TALC (UNII: 7SEV7J4R1U)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
TRIACETIN (UNII: XHX3C3X673)

Product Characteristics
Color	ORANGE	Score	no score
Shape	ROUND	Size	10mm
Flavor		Imprint Code	P
Contains

#	Item Code	Package Description	Marketing Start Date
Packaging
1	NDC:67618-310-01	1 in 1 CARTON	10/01/1974
1		10 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:67618-310-30	1 in 1 CARTON	10/01/1974
2		30 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product
3	NDC:67618-310-60	1 in 1 CARTON	10/01/1974
3		60 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M007	10/01/1974

Labeler - Atlantis Consumer Healthcare, Inc. (118983925)

Registrant - Atlantis Consumer Healthcare, Inc. (118983925)